User:Mr. Ibrahem/Pegvisomant

Pegvisomant, sold under the brand name Somavert, is a medication used to treat acromegaly. It maybe used when the condition is not controlled by surgery, radiation therapy and somatostatins. It is given by injection under the skin.

Most side effects are mild to moderate. Common side effects include headache, diarrhea, and joint pain. Other side effects may include liver problems and low blood sugar. While there is no evidence of harm in pregnancy, such use has not been well studied. It is a growth hormone receptor blocker.

Pegvisomant was approved for medical use in Europe in 2002 and the United States in 2003. In the United Kingdom it costs the NHS about £1,500 a month at 10 mg per day as of 2021. This amount in the United States is about 7,500 USD.